DE69233612D1 - Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz - Google Patents

Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz

Info

Publication number
DE69233612D1
DE69233612D1 DE69233612T DE69233612T DE69233612D1 DE 69233612 D1 DE69233612 D1 DE 69233612D1 DE 69233612 T DE69233612 T DE 69233612T DE 69233612 T DE69233612 T DE 69233612T DE 69233612 D1 DE69233612 D1 DE 69233612D1
Authority
DE
Germany
Prior art keywords
peptide sequence
pct
functional diversity
structural
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233612T
Other languages
English (en)
Other versions
DE69233612T2 (de
Inventor
Sacha Kallenbach
Noelle Doyen
Francois Rougeon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE69233612D1 publication Critical patent/DE69233612D1/de
Application granted granted Critical
Publication of DE69233612T2 publication Critical patent/DE69233612T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1024—In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1264—DNA nucleotidylexotransferase (2.7.7.31), i.e. terminal nucleotidyl transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69233612T 1991-12-11 1992-12-11 Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz Expired - Fee Related DE69233612T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9115389A FR2685004A1 (fr) 1991-12-11 1991-12-11 Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique.
FR9115389 1991-12-11
PCT/FR1992/001178 WO1993012228A1 (fr) 1991-12-11 1992-12-11 Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique

Publications (2)

Publication Number Publication Date
DE69233612D1 true DE69233612D1 (de) 2006-05-18
DE69233612T2 DE69233612T2 (de) 2007-07-05

Family

ID=9419935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233612T Expired - Fee Related DE69233612T2 (de) 1991-12-11 1992-12-11 Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz

Country Status (11)

Country Link
US (1) US5756323A (de)
EP (1) EP0618965B1 (de)
JP (1) JPH07504086A (de)
AT (1) ATE322543T1 (de)
CA (1) CA2125192A1 (de)
DE (1) DE69233612T2 (de)
DK (1) DK0618965T3 (de)
ES (1) ES2260753T3 (de)
FR (1) FR2685004A1 (de)
PT (1) PT618965E (de)
WO (1) WO1993012228A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US7122339B2 (en) 1998-10-09 2006-10-17 Medical Research Council Method for generating diversity
CA2675802A1 (en) * 1998-10-09 2000-04-20 Medical Research Council Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product
EP1010763A1 (de) * 1998-12-11 2000-06-21 Institut Pasteur Verstärkte Expression von heterologen Proteine in rekombinanten Bakterien durch erniedrigter Wachstemperatur und Co-expression von seltenen tRNA's
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
WO2005007823A2 (en) * 2003-07-11 2005-01-27 New York University Compositions, kits, and methods for stimulation of homologous recombination
WO2008103474A1 (en) 2007-02-20 2008-08-28 Anaptysbio, Inc. Methods of generating libraries and uses thereof
US8012714B2 (en) * 2008-04-14 2011-09-06 Innovative Targeting Solutions, Inc. Sequence diversity generation in immunoglobulins
EP2412806B1 (de) 2010-07-28 2014-01-08 Institut Pasteur Verwendung von terminaler Desoxynucleotidyltransferase zur mutagenen DNA-Reparatur zur Erzeugung von Variabilität an einer bestimmten Position in DNA
CA2867235C (en) 2012-03-14 2021-11-09 Innovative Targeting Solutions Inc. Generating targeted sequence diversity in fusion proteins
WO2013134880A1 (en) 2012-03-14 2013-09-19 Innovative Targeting Solutions Inc. Generating targeted sequence diversity in proteins

Also Published As

Publication number Publication date
US5756323A (en) 1998-05-26
JPH07504086A (ja) 1995-05-11
WO1993012228A1 (fr) 1993-06-24
DE69233612T2 (de) 2007-07-05
DK0618965T3 (da) 2006-08-14
ES2260753T3 (es) 2006-11-01
CA2125192A1 (fr) 1993-06-24
FR2685004B1 (de) 1995-01-06
ATE322543T1 (de) 2006-04-15
EP0618965B1 (de) 2006-04-05
PT618965E (pt) 2006-08-31
FR2685004A1 (fr) 1993-06-18
EP0618965A1 (de) 1994-10-12

Similar Documents

Publication Publication Date Title
DE69233612D1 (de) Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz
HK1124077A1 (en) Kdr peptides and vaccines comprising the same
DE3772485D1 (de) Rekombinante dns-sequenzen, diese enthaltende vektoren und verfahren zur verwendung derselben.
NZ504214A (en) Recombination cloning using nucleic acids having recombination sites
ATE399858T1 (de) Blütenorgan-spezifische promotersequenzen
ATE317019T1 (de) Rekombinanter vektor, der infektiöse virale genomsequenzen mit einer grösse von mehr als 100 kb enthält, verfahren zu seiner herstellung und verwendung
PL313445A1 (en) Grb3-3 gene, variants thereof and their use
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
ATE296835T1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
EP0643768A4 (de) Oligonukleotidsequenzen und transgene tiere die damit transfektiert wurden besitzen eine reduzierte sensitivität gegen narkkotische analgetika.
ATE374255T1 (de) Doping bei der walk-through-mutagenese
NO20020941D0 (no) Regulerende sekvenser med virkning i tråddannende sopp
ATE329041T1 (de) Nukleinsäurefragmente, rekombinante vektoren, welche diese enthalten und verfahren zum unterstützen der expression von strukturellen genen durch anwendung derselben
CA2419038A1 (en) Nucleic acid and protein increasing expression levels under salt stress
Major et al. Conformational distortions Induced in DNA upon binding of cisplatin and intercalating analogues

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee